Chemoinformaics analysis of HEXYL (E)-2-METHYLPENT-3-ENOATE
Molecular Weight | 198.306 | nRot | 7 |
Heavy Atom Molecular Weight | 176.13 | nRig | 7 |
Exact Molecular Weight | 198.162 | nRing | 0 |
Solubility: LogS | -3.194 | nHRing | 0 |
Solubility: LogP | 2.819 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 36.3134 |
nHD | 0 | BPOL | 24.6746 |
QED | 0.72 |
Synth | 1.592 |
Natural Product Likeliness | 0.178 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.005 |
HIA | 0.005 |
CACO-2 | -4.511 |
MDCK | 0.0000215 |
BBB | 0.566 |
PPB | 0.747091 |
VDSS | 0.488 |
FU | 0.246409 |
CYP1A2-inh | 0.958 |
CYP1A2-sub | 0.631 |
CYP2c19-inh | 0.825 |
CYP2c19-sub | 0.138 |
CYP2c9-inh | 0.573 |
CYP2c9-sub | 0.918 |
CYP2d6-inh | 0.282 |
CYP2d6-sub | 0.606 |
CYP3a4-inh | 0.093 |
CYP3a4-sub | 0.215 |
CL | 11.326 |
T12 | 0.865 |
hERG | 0.048 |
Ames | 0.132 |
ROA | 0.837 |
SkinSen | 0.439 |
Carcinogencity | 0.396 |
EI | 0.987 |
Respiratory | 0.171 |
NR-Aromatase | 0.045 |
Antiviral | Yes |
Prediction | 0.610584 |